In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA nanotech meeting

This article was originally published in The Rose Sheet

Executive Summary

Pre-registration for the Oct. 10 Nanotechnology Task Force public meeting on nanotechnology closed Sept. 29, however, there will be on-site registration on a first-come, first-served basis until the room capacity is reached, FDA announces in a Sept. 26 Federal Register 1notice. The meeting, which will address the types of nanotechnology material products under development in the areas of foods, drugs and cosmetics, will be held in the Natcher Auditorium at the National Institutes of Health campus in Bethesda, Md. FDA announced plans for the meeting in April (2"The Rose Sheet" April 17, 2006, In Brief)...

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts